FDA Approves New Therapy for Rare Disease Affecting Optic Nerve, Spinal Cord
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Uplizna (inebilizumab-cdon) injection for intravenous use for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients with a …
Read More